Global Hyperlipidemia Drugs Market: Future Prospects and Innovations by 2034
Hyperlipidemia is one of the most common metabolic disorders worldwide and a major risk factor for cardiovascular diseases, stroke, and peripheral artery disease. The condition is characterized by elevated levels of cholesterol and triglycerides in the bloodstream, necessitating long-term treatment and monitoring. Growing awareness regarding cardiovascular health, increasing screening programs,...
0 Commentaires 0 Parts 5 Vue 0 Aperçu